Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial

• Masashi Sakuma ,

  Contributed equally to this work with: Masashi Sakuma, Teruo Inoue

  Roles Data curation, Formal analysis, Methodology, Project administration, Writing – original draft

  * E-mail: masakuma@dokkyomed.ac.jp

  Affiliation Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan

  https://orcid.org/0000-0002-3892-0799

  ⨯
• Shigeru Toyoda,

  Roles Investigation

  Affiliation Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan

  ⨯
• Takuo Arikawa,

  Roles Investigation

  Affiliation Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan

  ⨯
• Yota Koyabu,

  Roles Investigation

  Affiliation Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan

  ⨯
• Toru Kato,

  Roles Investigation

  Affiliation Department of Clinical Research, National Hospital Organization Tochigi Medical Center, Utsunomiya, Japan

  ⨯
• Taichi Adachi,

  Roles Investigation

  Affiliation Department of Cardiology, National Hospital Organization Tochigi Medical Center, Utsunomiya, Japan

  ⨯
• Hideaki Suwa,

  Roles Investigation

  Affiliation Department of Cardiology, National Hospital Organization Tochigi Medical Center, Utsunomiya, Japan

  ⨯
• Jun-ichi Narita,

  Roles Investigation

  Affiliation Department of Neurosurgery, Tochigi Medical Center Tochinoki, Tochigi, Japan

  ⨯
• Koetsu Anraku,

  Roles Investigation

  Affiliation Department of Internal Medicine, Tochigi Medical Center Tochinoki, Tochigi, Japan

  ⨯
• Kimihiko Ishimura,

  Roles Investigation

  Affiliation Department of Internal Medicine, Tochigi Medical Center Tochinoki, Tochigi, Japan

  ⨯
• Fumitake Yamauchi,

  Roles Investigation

  Affiliation Department of Cardiology, Yuai Memorial Hospital, Koga, Japan

  ⨯
• Yasunori Sato,

  Roles Data curation, Validation

  Affiliation Department of Preventive Medicine and Public Health, Keio University School of Medicine, Shinanomachi, Japan

  ⨯
• Teruo Inoue

  Contributed equally to this work with: Masashi Sakuma, Teruo Inoue

  Roles Methodology, Supervision, Writing – review & editing

  Affiliation Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan

  ⨯